Skip to content

Search

Fearless Mikayla: Why we research Down syndrome

Eight-year-old Mikayla is the miracle child her parents never thought they would have. They’d tried for seven years to have a baby, and when Mikayla was finally born they couldn’t contain their excitement or pride. The fact she had Down syndrome was secondary.

The Power of Why

Our job is to find the answers. It's helping us change kids' lives. See the "why?"s we're asking and answering.

Launching The Kids

Western Australia’s biggest and only medical research institute dedicated to improving kids’ health and wellbeing, has rebranded to The Kids Research Institute Australia.

Helping kids stay safe and strong online

Learn how our research is preventing cyberbullying and supporting kids’ mental wellbeing

The idea that changed kids’ health forever

Hear how one bold idea became a world-leading institute for kids’ health.

How April got her spark back after T1D diagnosis

Discover how our breakthroughs are helping kids with diabetes live longer, safer lives.

A diagnostic test for acute rheumatic fever (pilot study)

Currently there are no diagnostic tests for ARF, and no treatments targeting immune responses to improve disease outcomes.

Skin health of Aboriginal children living in urban communities

Skin concerns are frequent among urban-living Aboriginal children, yet specialist dermatology consultations are limited with studies highlighting the need for improved cultural security. Through newly established paediatric dermatology clinics at two urban Aboriginal Community Controlled Health Organisations (ACCHOs), we aimed to describe clinic and patient data, including disease frequencies and associations, to inform dermatology service provision and advocacy. 

Propofol, Anesthesia, and Neurocognitive Outcomes in Patients with Pediatric Leukemia: Are We Missing the Forest for the Trees?

Britta Regli-von Ungern-Sternberg AM FAHMS MD, PhD, DEAA, FANZA Chair of Paediatric anaesthesia, University of Western Australia; Consultant

Phage therapy could be key to conquering persistent bacterial lung infections in children

Persistent bacterial lung infections in children lead to significant morbidity and mortality due to antibiotic resistance. In this paper, we describe how phage therapy has shown remarkable efficacy in preclinical and clinical studies, demonstrating significant therapeutic benefits through various administration routes.